Anbio Biotechnology (NNNN)

$5.67 -0.10 (-1.73%)
Market Cap N/A
Revenue (ttm) 6.71M
Net Income (ttm) 2.25M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 33.58%
Debt to Equity Ratio N/A
Volume 395,500
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Latest News on NNNN

U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small Listings

Feb 22, 2025, 12:40 AM EST - 2 months ago

U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small Listings

AURN KMTS ODTX ONE WGRX

Anbio Biotechnology Announces Closing of Initial Public Offering

Feb 20, 2025, 9:50 AM EST - 2 months ago

Anbio Biotechnology Announces Closing of Initial Public Offering

Anbio Biotechnology Announces Pricing of Initial Public Offering

Feb 18, 2025, 6:10 PM EST - 2 months ago

Anbio Biotechnology Announces Pricing of Initial Public Offering

U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings

Jan 4, 2025, 12:30 AM EST - 4 months ago

U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings

AERO CAPS CRGT FBGL FLOC INLF INR

Anbio Biotechnology Pursues U.S. IPO For Its IVD Products Launch

Jan 2, 2025, 12:06 PM EST - 4 months ago

Anbio Biotechnology Pursues U.S. IPO For Its IVD Products Launch

Anbio Biotechnology IPO Registration Document (F-1)

Dec 31, 2024, 5:21 PM EST - 4 months ago

Anbio Biotechnology IPO Registration Document (F-1)